AU2002239771A1 - Methods of predicting chemotherapy response - Google Patents
Methods of predicting chemotherapy responseInfo
- Publication number
- AU2002239771A1 AU2002239771A1 AU2002239771A AU3977102A AU2002239771A1 AU 2002239771 A1 AU2002239771 A1 AU 2002239771A1 AU 2002239771 A AU2002239771 A AU 2002239771A AU 3977102 A AU3977102 A AU 3977102A AU 2002239771 A1 AU2002239771 A1 AU 2002239771A1
- Authority
- AU
- Australia
- Prior art keywords
- methods
- chemotherapy response
- predicting chemotherapy
- predicting
- response
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24705300P | 2000-11-13 | 2000-11-13 | |
US60/247,053 | 2000-11-13 | ||
PCT/US2001/051191 WO2002046750A2 (en) | 2000-11-13 | 2001-11-12 | Methods of predicting chemotherapy response |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002239771A1 true AU2002239771A1 (en) | 2002-06-18 |
Family
ID=22933356
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002239771A Abandoned AU2002239771A1 (en) | 2000-11-13 | 2001-11-12 | Methods of predicting chemotherapy response |
AU2002241791A Abandoned AU2002241791A1 (en) | 2000-11-13 | 2001-11-13 | Methods of predicting chemotherapy response |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002241791A Abandoned AU2002241791A1 (en) | 2000-11-13 | 2001-11-13 | Methods of predicting chemotherapy response |
Country Status (2)
Country | Link |
---|---|
AU (2) | AU2002239771A1 (en) |
WO (2) | WO2002046750A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005053704A1 (en) * | 2003-12-01 | 2005-06-16 | Novartis Ag | Method for predicting drug responsiveness in myeloid neoplasms |
SG10201402346UA (en) * | 2009-05-19 | 2014-10-30 | Vivia Biotech Sl | Methods for providing personalized medicine tests ex vivo for hematological neoplasms |
BR112012024619A2 (en) * | 2010-03-31 | 2016-05-31 | Diatech Oncology Llc | system and method for evaluating anticancer drug candidate |
US9476871B2 (en) | 2012-05-02 | 2016-10-25 | Diatech Oncology Llc | System and method for automated determination of the relative effectiveness of anti-cancer drug candidates |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6077684A (en) * | 1996-11-14 | 2000-06-20 | Vanderbilt University | Automated assay for measuring apoptosis in cell culture |
-
2001
- 2001-11-12 AU AU2002239771A patent/AU2002239771A1/en not_active Abandoned
- 2001-11-12 WO PCT/US2001/051191 patent/WO2002046750A2/en not_active Application Discontinuation
- 2001-11-13 AU AU2002241791A patent/AU2002241791A1/en not_active Abandoned
- 2001-11-13 WO PCT/US2001/051196 patent/WO2002046751A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2002241791A1 (en) | 2002-06-18 |
WO2002046750A2 (en) | 2002-06-13 |
WO2002046751A3 (en) | 2004-01-08 |
WO2002046750A3 (en) | 2003-02-13 |
WO2002046751A9 (en) | 2002-12-27 |
WO2002046751A2 (en) | 2002-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002305804A1 (en) | Retaining wall block | |
AU2002258941A1 (en) | Methods of enhancing cell responsiveness | |
AU2002304752A1 (en) | Drag and drop technique for building queries | |
AU2002356333A1 (en) | Bore isolation | |
AU2002339348A1 (en) | Inhibition of STAT-1 | |
AU2002236477A1 (en) | Fgf-affinity chromatography | |
AU1488501A (en) | Methods of inhibiting metastasis | |
AU2002358179A1 (en) | New rennets | |
AU2001259620A1 (en) | Building block set | |
AU2002241791A1 (en) | Methods of predicting chemotherapy response | |
AU2001271033A1 (en) | Means of assaying immune function | |
AUPR843201A0 (en) | Wall construction method | |
AU2001267716A1 (en) | Method for predicting flow properties of powders | |
AUPS329502A0 (en) | Block wall systems | |
AU2001284265A1 (en) | Genetic study | |
AU2001290731A1 (en) | Structural prediction of allosterism | |
AU8577201A (en) | Chromatographic interseparation of platinum group metals | |
AU2001258330A1 (en) | New uses of imidazolylmethyl-pyridines | |
AU2002349485A1 (en) | Cell migration inhibitor | |
AU5052701A (en) | Block construction | |
AU2002342742A1 (en) | Method for predicting the sensitivity to chemotherapy | |
AU2001293215A1 (en) | Global network computers | |
AUPQ580300A0 (en) | Genetic analysis | |
AU2003247440A1 (en) | Retaining wall block | |
AU2002343388A1 (en) | Porous pipe |